NASA's Twins Study Hints Space Travel Reshapes Gut Bacteria, With Brain Consequences
A new review pulls together spaceflight missions, ground-based simulations, and animal studies to map how microgravity throws off astronauts' gut bacteria — and traces a plausible line from that disruption to cognitive and mood changes in orbit.
The Core Issue
Astronauts already deal with muscle loss, radiation exposure, and disrupted sleep in orbit. This review, from researchers at Manipal Academy of Higher Education, adds another item to that list: microgravity appears to systematically disrupt the gut microbiome — the community of bacteria that helps regulate digestion, immunity, and, increasingly, brain function. As missions stretch toward the Moon and eventually Mars, lasting two to three years instead of six to twelve months, understanding whether that disruption reaches the brain becomes a much bigger deal.
Get the checklist before you trust another gut health headline.
Every week a new study claims one probiotic strain will fix everything. We built a 5-point checklist that shows you which microbiome claims are backed by real trials and which ones are riding on 8 mice and a press release.
The Finding
The authors pulled together evidence from real spaceflight missions (including NASA's Twins Study), ground-based simulations like head-down bed rest and hindlimb unloading in rodents, and even non-human primate studies. The pattern holds up with real consistency across very different setups: time in microgravity depletes several protective bacterial species, most reproducibly Akkermansia muciniphila (which supports the gut lining), Faecalibacterium prausnitzii (a major producer of the anti-inflammatory compound butyrate), and Bifidobacterium and Ruminococcus species (both involved in fiber fermentation and immune regulation). More opportunistic, less beneficial bacteria tend to move in as these decline.
Interestingly, the broader ratio between two major bacterial phyla (Firmicutes and Bacteroidetes) — often used as a general dysbiosis marker — swings in different directions across different studies and models. The authors argue that's actually informative: it suggests coarse phylum-level ratios are a less reliable signal of spaceflight's effect than the loss of these specific, function-relevant bacterial species and the metabolites they produce.
Mechanistically, the review lays out several reasons microgravity disrupts the gut this directly: it changes how the intestines physically move contents (motility), shifts roughly one to two liters of fluid toward the head and chest which affects blood flow to the gut, dysregulates the immune system in ways that let opportunistic bacteria expand, activates stress hormones that reshape bacterial populations, and pairs with a low-fiber, shelf-stable astronaut diet that starves fiber-fermenting bacteria of what they need.
Why It Matters
Once these protective bacteria disappear, several consequences cascade outward. Short-chain fatty acid production drops — these are the molecules, especially butyrate, that keep the gut lining sealed and calm inflammation. The gut barrier gets leakier, allowing bacterial fragments like lipopolysaccharide to leak into the bloodstream and trigger low-grade, body-wide inflammation. That inflammation has a documented path to the brain — through immune signaling, hormonal pathways, and the vagus nerve, the body's primary gut-to-brain communication cable. In mouse studies, the review notes, blocking normal gut bacteria increases the permeability of the blood-brain barrier itself, and restoring bacteria (or simply giving butyrate) reverses that.
In real astronauts and people in ground-based analog studies, this lines up with measurable changes: reduced manual dexterity, worse performance juggling two tasks at once, weaker spatial memory, and reports of low mood and anxiety, alongside brain imaging showing altered grey matter, white matter, and enlarged fluid-filled ventricles. NASA's Twins Study specifically found the astronaut twin had reduced levels of a gut-derived compound called indole-3-propionic acid, which has antioxidant, brain-protective properties, along with elevated levels of toxic byproducts normally cleared by the kidneys.
Limitations of the Study
This is a review paper, not new data — it synthesizes findings across dozens of separate studies rather than running new experiments. Much of the human evidence comes from small analog cohorts (often under 15 people) and, most strikingly, from a single set of twins — one in space, one on the ground — which is a landmark study design but statistically an n of one per condition. The authors are explicit that they can't yet prove dysbiosis causes the cognitive changes seen in astronauts; the two show up together consistently, but teasing apart microgravity's role from radiation exposure, stress, diet, and disrupted sleep in the same missions remains genuinely difficult. Animal models like hindlimb-unloaded mice also differ from humans in gut microbiome composition, even where function is preserved.
Interesting Statistics
- 5-fold depletion: Astronauts on 6–12 month ISS missions showed depletion of Akkermansia and Ruminococcus by more than 5-fold, and Pseudobutyrivibrio and Fusicatenibacter by roughly 3-fold.
- 14-day shift: Even a 14-day spaceflight was enough to reduce Lactobacillus and Bifidobacterium while increasing Bacteroides.
- 1–2 liters fluid shift: Microgravity-driven fluid shift moves roughly 1–2 liters of fluid from the lower body toward the head and chest.
- Systemic impacts: Mice on a 77-day ISS mission showed microbiome changes tied to measurable bone loss, not just gut symptoms.
- Sample constraints: Human spaceflight microbiome cohorts rarely exceed 10–15 subjects, limiting statistical power.
Useful Takeaways
The review frames the gut microbiome as both a sensitive early-warning indicator of spaceflight stress and a genuinely tractable target for intervention — unlike bone density loss or radiation exposure, dysbiosis can plausibly be addressed with probiotics, prebiotics, diet changes, or direct metabolite supplementation like butyrate. The authors call for testing specific probiotic strains for stability and safety on long missions, developing real-time biomarkers (fecal short-chain fatty acid levels, inflammatory markers, blood toxin levels) that could be monitored during flight, and running better-controlled studies that can separate microgravity's role from radiation's using combined ground and orbital experiments.
TL;DR
A new review argues that time in microgravity consistently depletes several protective gut bacteria species, and that this disruption plausibly contributes to the cognitive dips, mood changes, and brain structure shifts seen in astronauts — through inflammation, a leakier gut barrier, and direct signaling to the brain via the vagus nerve. The evidence is real but still correlational, built mostly on small human studies (including NASA's single Twins Study) plus animal work, so the authors treat it as a strong hypothesis worth targeted countermeasures rather than a settled cause-and-effect finding.